Clene Inc Stock In The News

CLNN Stock  USD 4.97  0.04  0.81%   
Our overall analysis of Clene's news coverage and content from conventional and social sources shows investors' bearish mood towards Clene Inc. The specific impact of Clene news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Clene's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Clene headlines in addition to utilizing other, more conventional financial analysis modules. Check out Clene Backtesting and Clene Hype Analysis.

Clene Today Top News and Investor Outlook

Yahoo News
Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment
https://finance.yahoo.com/news/clene-visionary-ms-trial-data-133000040.html
 Bullish
Yahoo News
Clene Announces Significant Positive Results from LTE VISIONARY-MS Trial
https://finance.yahoo.com/news/clene-announces-significant-positive-results-140000635.html
 Bullish
Yahoo News
Clene Reports Significant Improvement in Vision and Cognition With CNM-Au8® Treatment in VISIONARY-MS Trial Long-Term Open Label Extension
https://finance.yahoo.com/news/clene-reports-significant-improvement-vision-120000893.html
 Bullish
Yahoo News
Clene's Phase 2 REPAIR-PD and REPAIR-MD Trials Support Advancement to Phase 3
https://finance.yahoo.com/news/clenes-phase-2-repair-pd-212519799.html
 Bullish
Yahoo News
Clene Announces New Data from HEALEY ALS Platform Trial
https://finance.yahoo.com/news/clene-announces-data-healey-als-200000067.html
 Bullish
Yahoo News
Clene Reports Reduction in Biomarker Pla...
https://finance.yahoo.com/news/clene-reports-reduction-biomarker-plasma-120000900.html
 Neutral
Yahoo News
Clene Provides Update on ALS Clinical Development Meeting With FDA
https://finance.yahoo.com/news/clene-provides-als-clinical-development-120000308.html
 Bullish
Yahoo News
How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders
https://finance.yahoo.com/news/clene-cnm-au8-r-takes-140000265.html
 Bullish
Yahoo News
Clene Lead Drug Candidate Featured in Peer-Reviewed Publication
https://finance.yahoo.com/news/clene-lead-drug-candidate-featured-200000901.html
 Bullish
Yahoo News
Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Brain Target Engagement In Neurodegenerative Diseases
https://finance.yahoo.com/news/clene-announces-peer-reviewed-publication-133600949.html
 Bullish

Clene Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Clene and other traded companies coverage with news coverage. We help investors stay connected with Clene headlines for the 12th of December 2024 to make an informed investment decision based on correlating the impacts of news items on Clene Stock performance. Please note that trading solely based on the Clene Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Clene's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Clene Inc investors visualize upcoming and past events in order to time the market based on Clene Inc noise-free hype analysis.
Clene stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Clene earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Clene that are available to investors today. That information is available publicly through Clene media outlets and privately through word of mouth or via Clene internal channels. However, regardless of the origin, that massive amount of Clene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Clene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Clene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Clene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Clene alpha.

Clene Largest EPS Surprises

Earnings surprises can significantly impact Clene's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-08
2024-03-31-0.08-0.09-0.0112 
2024-03-13
2023-12-31-0.07-0.060.0114 
2022-05-09
2022-03-31-0.19-0.21-0.0210 
2022-11-07
2022-09-30-0.22-0.170.0522 
2021-08-10
2021-06-30-0.15-0.21-0.0640 
2023-11-07
2023-09-30-0.09-0.020.0777 
View All Earnings Estimates

Clene Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Clene Inc Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
Yahoo News
11th of December 2024
IBN Coverage Clene Advances CNM-Au8 in ALS With FDA Guidance on Accelerated Approval Pathw...
at finance.yahoo.com 
Macroaxis News
6th of December 2024
Acquisition by Kiernan Matthew of 2853 shares of Clene at 4.4 subject to Rule 16b-3
at MacroaxisInsider 
Investing News at Macroaxis
14th of November 2024
Canaccord cuts Clene stock target, holds buy rating on FDA meeting
at investing.com 
zacks News
13th of November 2024
Clene Inc. Reports Q3 Loss, Misses Revenue Estimates
at zacks.com 
Google News at Macroaxis
23rd of October 2024
Clene Unveils Phase 3 Trial Design at NEALS - TipRanks
at news.google.com 
Yahoo News
11th of October 2024
IBN Coverage Clene Closes 7.3M Registered Direct Offering and Concurrent Private Placement...
at finance.yahoo.com 
news
10th of October 2024
Acquisition by Jacobovitz Shalom of 30000 shares of Clene at 0.37 subject to Rule 16b-3
at Jacobovitz Shalom 
Yahoo News
9th of October 2024
IBN Coverage Clene Announces Participation at Two Upcoming Investor Conferences
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
2nd of October 2024
Insider Buying Chief Science Officer Mark Mortenson Acquires Shares of Clene Inc
at gurufocus.com 
news
19th of September 2024
HC Wainwright Reaffirms Buy Rating for Clene
at thelincolnianonline.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Clene in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Clene's short interest history, or implied volatility extrapolated from Clene options trading.
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:
Check out Clene Backtesting and Clene Hype Analysis.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.614
Earnings Share
(5.29)
Revenue Per Share
0.069
Quarterly Revenue Growth
(0.66)
Return On Assets
(0.42)
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.